Skip to main navigation Skip to search Skip to main content

A Phase 1-2, Double-Blind, Sham-Controlled Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Patients with MECP2 Duplication Syndrome

Project: Contract research › Industry project

Project Details

AcronymATTUNE
StatusActive
Effective start/end date14.11.2025 → 13.11.2029

Fields of science

  • 301405 Neuropathology
  • 302052 Neurology
  • 302035 Paediatrics and adolescent medicine
  • 302051 Neurosurgery
  • 301114 Cell biology
  • 106013 Genetics